News

Modulus Discovery, Inc. to Change Its Name to Alivexis, Inc. on March 11, 2024- 11 March, 2024

Modulus Discovery, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference- 09 January, 2024

PeptiDream and Modulus Announce Nomination of First Clinical Development Candidate from Strategic Partnership- 03 August, 2023

Modulus Discovery has been selected as a “J-Startup” company by the Ministry of Economy, Trade and Industry of Japan- 06 April, 2023

Modulus Discovery, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference- 13 December, 2022

Modulus Discovery Announces Research Collaboration with Fujitsu on the Implementation and Optimization of ModBind™, A Novel Computational Technology for Drug Discovery- 08 August, 2022

Modulus Discovery Closes $20.4M USD Series C- 01 March, 2022

40th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation- 14 January, 2022

Nissan Chemical and Modulus Discovery Jointly Announce Signing of Strategic Drug Discovery Collaboration Agreement- 21 April, 2021

39th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation- 26 January, 2021